Merrill Lynch MITTS ML EuroFund Index due 2/28/2006
Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 Fundamental Analysis
Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 (EFM) shows weak financial fundamentals with a PE ratio of 76.27, profit margin of 1.46%, and ROE of 5.54%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 63.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze EFM's fundamental strength across five key dimensions:
Efficiency Score
WeakEFM struggles to generate sufficient returns from assets.
Valuation Score
ModerateEFM shows balanced valuation metrics.
Growth Score
WeakEFM faces weak or negative growth trends.
Financial Health Score
ExcellentEFM maintains a strong and stable balance sheet.
Profitability Score
WeakEFM struggles to sustain strong margins.
Key Financial Metrics
Is EFM Expensive or Cheap?
P/E Ratio
EFM trades at 76.27 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, EFM's PEG of 0.76 indicates potential undervaluation.
Price to Book
The market values Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 at 2.43 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.39 times EBITDA. This is generally considered low.
How Well Does EFM Make Money?
Net Profit Margin
For every $100 in sales, Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 keeps $1.46 as profit after all expenses.
Operating Margin
Core operations generate 21.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.54 in profit for every $100 of shareholder equity.
ROA
Merrill Lynch MITTS ML EuroFund Index due 2/28/2006 generates $3.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.02 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
76.27
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.76
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
9.49
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.005
vs 25 benchmark
How EFM Stacks Against Its Sector Peers
| Metric | EFM Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 76.27 | 18.80 | Worse (Expensive) |
| ROE | 5.54% | 817.00% | Weak |
| Net Margin | 146.42% | -55.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 1.03 | Strong (Low Leverage) |
| Current Ratio | 9.49 | 661.52 | Strong Liquidity |
| ROA | 3.14% | -23757.00% (disorted) | Weak |
EFM outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Merrill Lynch MITTS ML EuroFund Index due 2/28/2006's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical